Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Kreeftmeijer Vegter, Annemarie R ^a,b   Van Genderen, Perry J ^c   Visser, Leo G ^d   Bierman, Wouter F W ^e   Clerinx, Jan ^f   Van Veldhuizen, Cees K W ^b   De Vries, Peter J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ACE Pharmaceuticals BV   (Netherlands)

^c Harbour Hospital   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

European traveller; Intravenous artesunate; Named patient program; Parasite clearance; Severe malaria

Indexed keywords

ARTESUNATE; MALACEF 60; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ANURIA; ANUS SPHINCTER DISORDER; APHASIA; ARTICLE; ATRIOVENTRICULAR BLOCK; BELGIUM; BRAIN EDEMA; CHILD; COMA; CONVULSION; DELIRIUM; DIARRHEA; DIPLOPIA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FEVER; FURUNCULOSIS; HEARING IMPAIRMENT; HEART ATRIUM FLUTTER; HEMOGLOBINURIA; HEMOLYTIC ANEMIA; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; MORTALITY; NETHERLANDS; NEUROLOGIC DISEASE; PARASITE CLEARANCE; PERIANAL ABSCESS; PNEUMONIA; PRESCHOOL CHILD; QT PROLONGATION; RASH; REACTIVE ARTHRITIS; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; SIDE EFFECT; SINUS BRADYCARDIA; SUPRAVENTRICULAR TACHYCARDIA; THROMBOCYTOPENIA; THROMBOPHLEBITIS; TREATMENT OUTCOME; ADOLESCENT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; TRAVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; ARTEMISININS; BELGIUM; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALARIA; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; TRAVEL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859010979     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-102     Document Type: Article

References (27)

1. Qinghaosu (artemisinin): the price of success. White NJ, Science 2008 320 330 334 10.1126/science.1155165 18420924 (Pubitemid 351555649)
2. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Dondorp A, Nosten F, Stepniewska K, Day N, White N, Lancet 2005 366 717 725 16125588 (Pubitemid 41207233)
3. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ, Lancet 2010 376 1647 1657 10.1016/S0140-6736(10)61924-1 21062666
4. World Health Organization, Guidelines for the Treatment of Malaria. Geneva 2006
5. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. Bruneel F, Tubach F, Corne P, Megarbane B, Mira JP, Peytel E, Camus C, Schortgen F, Azoulay E, Cohen Y, Georges H, Meybeck A, Hyvernat H, Trouillet JL, Frenoy E, Nicolet L, Roy C, Durand R, Le BJ, Wolff M, PLoS One 2010 5 13236 10.1371/journal.pone.0013236 20949045
6. Severe malaria and artesunate treatment, Norway. Morch K, Strand O, Dunlop O, Berg A, Langeland N, Leiva RA, Longva JA, Sjursen H, Skrede S, Sundal J, Jensenius M, Emerg Infect Dis 2008 14 1816 1818 10.3201/eid1411.080636 18976584
7. Intravenous artesunate for severe malaria in travelers, Europe. Zoller T, Junghanss T, Kapaun A, Gjorup I, Richter J, Hugo-Persson M, Morch K, Foroutan B, Suttorp N, Yurek S, Flick H, Emerg Infect Dis 2011 17 771 777 21529383
8. World Health Organization, WHO List of prequalified medicinal products 2011 http://apps.who.int/prequal/query/productregistry.aspx 16-5-2011
9. World Health Organization, Guidelines for the Treatment of Malaria. Geneva 2010
10. Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics. De Vries PJ, Bich NN, Van TH, Hung LN, Anh TK, Kager PA, Heisterkamp SH, Antimicrob Agents Chemother 2000 44 1302 1308 10.1128/AAC.44.5.1302-1308.2000 10770766 (Pubitemid 30228309)
11. Efficacy and safety of exchange transfusion as an adjunct therapy for severePlasmodium falciparumalaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol. van Genderen PJ, Hesselink DA, Bezemer JM, Wismans PJ, Overbosch D, Transfusion 2010 50 787 794 10.1111/j.1537-2995.2009.02488.x 19951317
12. Treatment of imported severe malaria with artesunate instead of quinine-more evidence needed? Cramer JP, Lopez-Velez R, Burchard GD, Grobusch MP, De Vries PJ, Malar J 2011 10 256 10.1186/1475-2875-10-256 21899729
13. [Haemolytic crisis of blackwater fever following artemether-lumefantrine intake](in French). Aloni NM, Nsangu M, Kunuanunua T, Kadima TB, Muanda TF, Bull SocPatholExot 2010 103 296 298
14. Resurgence of blackwater fever in long-term European expatriates in Africa: report of 21 cases and review. Bruneel F, Gachot B, Wolff M, Regnier B, Danis M, Vachon F, Clin Infect Dis 2001 32 1133 1140 10.1086/319743 11283802 (Pubitemid 32381119)
15. The course of anaemia after the treatment of acute, falciparum malaria. Camacho LH, Gordeuk VR, Wilairatana P, Pootrakul P, Brittenham GM, Looareesuwan S, Ann Trop Med Parasitol 1998 92 525 537 10.1080/00034989859221 9797826 (Pubitemid 28365363)
16. Prolonged haemolyticanaemia in malaria and autoantibodies against triosephosphateisomerase. Ritter K, Kuhlencord A, Thomssen R, Bommer W, Lancet 1993 342 1333 1334 10.1016/0140-6736(93)92248-R 7901638 (Pubitemid 23345182)
17. Hemolytic anemia. Dhaliwal G, Cornett PA, Tierney LM Jr, Am Fam Physician 2004 69 2599 2606 15202694 (Pubitemid 38720446)
18. False-positive serological tests in acute malaria. Ghosh K, Javeri KN, Mohanty D, Parmar BD, Surati RR, Joshi SH, Br J Biomed Sci 2001 58 20 23 11284219 (Pubitemid 32239029)
19. Immune hemolytic anemia associated with drug therapy. Garratty G, Blood Rev 2010 24 143 150 10.1016/j.blre.2010.06.004 20650555
20. A method for estimating the probability of adverse drug reactions. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ, ClinPharmacolTher 1981 30 239 245 (Pubitemid 12149145)
21. The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Newton PN, Barnes KI, Smith PJ, Evans AC, Chierakul W, Ruangveerayuth R, White NJ, Eur J ClinPharmacol 2006 62 1003 1009 (Pubitemid 44786491)
22. Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. Longo M, Zanoncelli S, Manera D, Brughera M, Colombo P, Lansen J, Mazue G, Gomes M, Taylor WR, Olliaro P, ReprodToxicol 2006 21 83 93 (Pubitemid 43048778)
23. Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Berdelle N, Nikolova T, Quiros S, Efferth T, Kaina B, Mol Cancer Ther 2011 10 2224 2233 10.1158/1535-7163.MCT-11-0534 21998290
24. A comparison of the in vivo kinetics ofPlasmodium falciparuring-infected erythrocyte surface antigen-positive and -negative erythrocytes. Newton PN, Chotivanich K, Chierakul W, Ruangveerayuth R, Teerapong P, Silamut K, Looareesuwan S, White NJ, Blood 2001 98 450 457 10.1182/blood.V98.2.450 11435316
25. Pitting function of the spleen in malaria: ultrastructural observations. Schnitzer B, Sodeman T, Mead ML, Contacos PG, Science 1972 177 175 177 10.1126/science.177.4044.175 4339353
26. Continuous-flow synthesis of the anti-malaria drug artemisinin. Levesque F, Seeberger PH, AngewChemInt Ed Engl 2012 51 1706 1709 10.1002/anie.201107446
27. Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs. Hale V, Keasling JD, Renninger N, Diagana TT, AmJTrop Med Hyg 2007 77 198 202